Provider review
YourHealthRx review
Sells both molecules as a dissolving tablet and an injection — and the cheaper route flips.
The injection undercuts the tablet on one molecule and the tablet undercuts the injection on the other.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
YourHealthRx
$140/mo sema injectable · $190/mo tirz injectable, four products
- Vs median
- $29/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog is the reason to look here: two molecules, each sold as an injection and as a tablet that dissolves in the mouth, four figures, all readable before any intake. If your plan is to hold a deliberately small amount, the tablet is the more forgiving instrument, and having it offered for both drugs rather than just the cheap one is uncommon. What is genuinely unusual is the direction of the pricing. On one molecule the injection is the cheaper option and the tablet carries a premium; on the other that reverses, and the tablet is the cheaper of the two. Everywhere else a seller picks a direction — needle-free is either the upgrade or the entry point — and applies it to the whole catalog. Here the answer depends on which molecule you are on, which means optimizing for cost you cannot carry a rule across from one drug to the other and have to check both. All four numbers are floors, so what any of them buys at the top of a range is unstated, and no milligram appears behind any of them. The compounded status and the FDA's non-approval of compounded preparations are both disclosed rather than left implicit.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a dissolving tablet available for either molecule, not just the cheaper one
- You want four figures visible before you answer anything
- You want compounded status and its regulatory position stated openly
Look elsewhere if
- You want one rule about which format is cheaper. It differs by molecule here
- You need a ceiling. All four figures are floors
- You want a dose behind the number. None is published
What it actually costs
Price as published
Four products, each with its own monthly figure: semaglutide injectable from $140/mo, semaglutide oral dissolving tablet from $170/mo, tirzepatide oral dissolving tablet from $180/mo and tirzepatide injectable from $190/mo · ★★ the cheaper route is not the same for both molecules — the injection undercuts the tablet on semaglutide by $30, and the tablet undercuts the injection on tirzepatide by $10 — so a reader choosing on cost would pick a different format depending on which drug they are on, which is a pattern nothing else here shows · ★ a dissolving tablet is offered for BOTH molecules rather than only the cheaper one, and that route matters for a small dose because it avoids drawing a partial unit into a syringe · every figure is an "as low as", so all four are floors with no ceiling published · compounded status is stated and the FDA's non-approval is disclosed · no dose is published behind any of the four
- Vs median
- $29/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ A dissolving tablet is offered for BOTH molecules rather than only the cheaper one, which matters for a small dose because it avoids drawing a partial unit into a syringe. ★★ The cheaper route is not the same for both drugs — the injection undercuts the tablet on one molecule and the tablet undercuts the injection on the other — so a reader optimizing for cost cannot carry a rule across from one to the other, a pattern nothing else here shows. Every figure is an "as low as" floor with no ceiling, and no dose is published behind any of the four. Compounded status and the FDA's non-approval are both disclosed.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both molecules are offered as a dissolving tablet as well as an injection.
- All four figures are stated as monthly rates and readable before intake.
- Compounded status and the FDA's non-approval are disclosed on the page.
Pharmacy, labs and oversight
YourHealthRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What YourHealthRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog is the reason to look here: two molecules, each sold as an injection and as a tablet that dissolves in the mouth, four figures, all readable before any intake. For a reader whose plan is to hold a deliberately small amount, the tablet is the more forgiving instrument, and having it offered for both drugs rather than just the cheap one is uncommon. What is genuinely unusual is the direction of the pricing. On semaglutide the injection is the cheaper option and the tablet carries a premium; on tirzepatide that reverses, and the tablet is the cheaper of the two. Everywhere else on this page a seller picks a direction — needle-free is either the upgrade or the entry point — and applies it to the whole catalog. Here the answer depends on which molecule you are on, which means a reader optimizing for cost cannot carry a rule across from one drug to the other and has to check both. All four numbers are floors, so what any of them buys at the top of a range is unstated, and no milligram appears behind any of them. The compounded status and the FDA's non-approval of compounded preparations are both disclosed rather than left implicit.
The honest cons
Every figure is an "as low as" floor with no ceiling published.
- The cheaper route differs by molecule, so no single rule applies to the catalog.
- No dose sits behind any of the four figures.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
YourHealthRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#287 of 373
Ordered with the companies that pay us first, and YourHealthRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Sublingual troches and drops
- Oral semaglutide (Rybelsus)
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.